Anti-Caveolin-1 antibody [7C8] - Caveolae Marker
- KO Validated
- Lab Essentials
- What is this?
4
(13 Reviews)
|
(42 Publications)
Mouse Monoclonal Caveolin-1 antibody. Suitable for ICC, ICC/IF and reacts with Human, Rat samples. Cited in 42 publications. Immunogen corresponding to Cell preparation containing Cav1 protein.
View Alternative Names
CAV, CAV1, Caveolin-1
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Caveolin-1 antibody [7C8] - Caveolae Marker (AB17052)
ab17052 staining Caveolin-1 in wild-type HeLa cells (top panel) and CAV1 knockout HeLa cells (ab255371) (bottom panel). The cells were fixed with 100% methanol (5 min) then permeabilized with 0.1% Triton X-100 for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1% PBS-Tween for 1h. The cells were then incubated with ab17052 at 1/500 dilution and ab6046 (Rabbit polyclonal to beta Tubulin) at 1/1000 dilution overnight at 4°C followed by a further incubation at room temperature for 1h with a goat secondary antibody to mouse IgG (Alexa Fluor® 488) (ab150117) at 2 μg/ml (shown in green) and a goat secondary antibody to rabbit IgG (Alexa Fluor® 594) (ab150080) at 2 μg/ml (shown in red). Nuclear DNA was labelled in blue with DAPI.
Image was taken with a confocal microscope (Leica-Microsystems TCS SP8).
- ICC
AbReview18155****
Immunocytochemistry - Anti-Caveolin-1 antibody [7C8] - Caveolae Marker (AB17052)
ab17052 staining Caveolin-1 in human Hacat keratinocyte cells by Immunocytochemistry/ Immunofluorescence. The cells were formaldehyde fixed, permeabilised in 0.1% Triton X-100 and then blocked using 1% serum for 1 hour at 25°C. Samples were then incubated with primary antibody at 1/75 for 24 hours at 4°C. The secondary antibody used was conjugated to Alexa Fluor® 488 (green) used at a 1/500 dilution.
This image is courtesy of an anonymous abreview.
- ICC
AbReview43982****
Immunocytochemistry - Anti-Caveolin-1 antibody [7C8] - Caveolae Marker (AB17052)
Immunocytochemical analysis of Mouse Bend.3 cells, labeling Caveolin-1 with ab17052. Cells were paraformaldehyde fixed, permeabilized with PBS + 0.1% Triton (PBT), and blocked with 10% serum for 1 hour at 22°C. Staining with ab17052 (diluted 1/200) was for 16 hours at 4°C.
This image is courtesy of an anonymous Abreview.
- WB
Lab
Western blot - Anti-Caveolin-1 antibody [7C8] - Caveolae Marker (AB17052)
Lanes 1 - 4 : Merged signal (red and green). Green - ab17052 observed at 21-24 kDa. Red - loading control, ab52866 (Rabbit anti-alpha Tubulin antibody [EP1332Y]) observed at 55kDa.
ab17052 was shown to react with Caveolin-1 in wild-type A431 cells in western blot. Loss of signal was observed when CAV1 knockout sample was used. Wild-type and CAV1 knockout A431 cell lysates were subjected to SDS-PAGE. Membranes were blocked in non-mammalian (TBS-based) blocking solution before incubation with ab17052 and ab52866 (Rabbit anti-alpha Tubulin antibody [EP1332Y]) overnight at 4°C at 1 μg/ml and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Mouse IgG H&L (IRDye® 800CW) preabsorbed (ab216772) and Goat anti-Rabbit IgG H&L (IRDye® 680RD) preabsorbed (ab216777) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-Caveolin-1 antibody [7C8] - Caveolae Marker (ab17052) at 1 µg/mL
Lane 1:
Wild-type A-431 (Human epidermoid carcinoma cell line) whole cell lysate at 20 µg
Lane 2:
CAV1 knockout A-431 (Human epidermoid carcinoma cell line) whole cell lysate at 20 µg
Lane 2:
Western blot - Human CAV1 (Caveolin-1) knockout A-431 cell line (<a href='/en-us/products/cell-lines/human-cav1-caveolin-1-knockout-a-431-cell-line-ab269583'>ab269583</a>)
Lane 3:
A549 (Human lung carcinoma cell line) whole cell lysate at 20 µg
Lane 4:
HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg
Predicted band size: 20 kDa
Observed band size: 21-24 kDa
false
- ICC
AbReview4874****
Immunocytochemistry - Anti-Caveolin-1 antibody [7C8] - Caveolae Marker (AB17052)
ab17052 at a 1/500 dilution staining hamster CHO cells by ICC/IF. The cells were paraformaldehyde fixed and blocked with 10% serum prior to incubation with the antibody. Bound antibody was detected using a FITC conjugated goat anti-mouse antibody.
This image is courtesy of an anonymous Abreview
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Caveolae provide a platform for various signaling pathways and involve caveolin-1 as a major component. Caveolin-1 interacts with multiple signaling molecules such as G-protein coupled receptors and Src family kinases to modulate signal transduction. This protein forms part of a larger caveolar complex contributing to cellular processes including endocytosis and lipid regulation. Its presence as a marker in caveolae highlights its significance in cellular functions.
Pathways
Caveolin-1 influences the insulin signaling and nitric oxide (NO) signaling pathways. In the insulin signaling pathway caveolin-1 interacts with insulin receptors to modulate glucose uptake. It also associates with eNOS (endothelial nitric oxide synthase) in the NO signaling pathway impacting vascular function. These relationships highlight its role in cellular communication and regulatory mechanisms within the human body.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (42)
Recent publications for all applications. Explore the full list and refine your search
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 12:e2408514 PubMed40192514
2025
Applications
Unspecified application
Species
Unspecified reactive species
Genes & development 39:463-489 PubMed40015991
2025
Applications
Unspecified application
Species
Unspecified reactive species
Radiation oncology (London, England) 19:82 PubMed38926892
2024
Applications
Unspecified application
Species
Unspecified reactive species
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 37:e23282 PubMed37994700
2023
Applications
Unspecified application
Species
Unspecified reactive species
Military Medical Research 10:53 PubMed37941054
2023
Applications
Unspecified application
Species
Unspecified reactive species
American journal of physiology. Heart and circulatory physiology 324:H553-H570 PubMed36827229
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cell and developmental biology 10:955676 PubMed36238686
2022
Applications
Unspecified application
Species
Unspecified reactive species
Science advances 8:eabc9061 PubMed35394844
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in physiology 13:825018 PubMed35250626
2022
Applications
Unspecified application
Species
Unspecified reactive species
BioFactors (Oxford, England) 48:67-85 PubMed34866251
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com